Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 572 of 1,261

  1. US 9943604

    Targeted therapeutic nucleosides and their use

    Ionis Pharmaceuticals, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  2. US 9944603

    Compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  3. US 9943505

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  4. US 9943609

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  5. US 9945864

    Disease-associated antigens and methods of use thereof

    The Regents of the University of California · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  6. US 9937243

    Sialylated glycoprotein compositions and uses thereof

    Ultragenyx Pharmaceutical Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  7. US 9938344

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  8. US 9938236

    Antiviral agents against HBV infection

    ARBUTUS BIOPHARMA CORPORATION · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  9. US 9937192

    Combination therapy to treat mycobacterium diseases

    SPERO TRINEM, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  10. US 9937157

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  11. US 9938353

    Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  12. US 9938272

    Hydrazine compound as blood coagulation factor Xa inhibitor

    North China Pharmaceutical Company., Ltd. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  13. US 9937129

    Materials and methods for delivering compositions to selected tissues

    The Regents of the University of California · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  14. US 9938531

    Compositions and methods for inhibiting expression of RRM2 genes

    Arrowhead Pharmaceuticals, Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  15. US 9938258

    Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof

    Karyopharm Therapeutics Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  16. US 9937222

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  17. US 9937266

    Oligomer-containing benzamide-based compounds

    Nektar Therapeutics · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  18. US 9937228

    Treatment of myocardial infarction by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  19. US 9938257

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  20. US 9938350

    Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

    The Regents of the University of California · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  21. US 9938259

    Therapeutic compositions and related methods of use

    Agios Pharmaceuticals, Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  22. US 9937217

    Method of inhibiting ABCG2 and related treatments

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  23. US 9937207

    Targeted disruption of T cell receptor genes using talens

    Sangamo Therapeutics, Inc. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  24. US 9937196

    Genomic sequence of avian paramyxovirus type 2 and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.